Crosscheck

Your medical. Crosschecked.

Check another medication

Anxiety

Other anti-anxiety medications

Anti-anxiety medication
Other names: clonazepam, Klonopin, diazepam, Valium, chlordiazepoxide, Librium

FAA guidance

Do not issue.

Examiner

Do not issue: the examiner cannot issue a certificate

FAA label

DO NOT ISSUE

Source: FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times. FAA date 30 September 2026. Checked by Crosscheck 14 October 2026

The FAA documents quoted here name the class, not this medication. Crosscheck matched it through its class: Anti-anxiety medication.

The FAA's Do Not Issue list names anti-anxiety medications under psychiatric or psychotropic medications, even when used for conditions other than mental health, and the FAA's table says the examiner should defer the exam; it also says do not issue a medical certificate.

Track your medications
Compare FAA documents: Other anti-anxiety medicationsWhat each of the two FAA documents says, in plain wordsOpen

It says some anti-anxiety medications are Do Not Fly, and its Do Not Fly list names four, "including but not limited to" alprazolam, lorazepam, temazepam and triazolam.

The FAA's psychiatric guidance says the use of anxiolytics is disqualifying and the examiner should defer issuance. Under controlled substances, the Do Not Issue list sends short-term use of anti-anxiety medication to the Do Not Fly section.

Show the FAA's words: Other anti-anxiety medicationsThe official FAA wording: four passages, each with its document and dateOpen
FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times · FAA date 30 September 2026
DO NOT ISSUE (DNI) MEDICATIONS
If the applicant is taking any of the following medications, AMEs should DEFER the exam. DO NOT issue a medical certificate to applicants who are using any of the following drug classes or medications for any condition:
PSYCHIATRIC OR PSYCHOTROPIC MEDICATIONS
Even when used for conditions other than mental health. Including but not limited to:
Anti-anxiety (some are DNF - see that section)
FAA, Exam Techniques – Item 47, Psychiatric Conditions · FAA date 29 July 2026
The use of a psychotropic drug is disqualifying for aeromedical certification purposes. This includes all sedatives, tranquilizers, antipsychotic drugs, antidepressant drugs (including SSRI's - see exceptions ), analeptics, anxiolytics, and hallucinogens. The Examiner should defer issuance and forward the medical records to the AMCD.
FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times · FAA date 30 September 2026
CONTROLLED SUBSTANCES (SCHEDULES I – V)
Any open prescription for chronic use of any drug or substance with no resolution. (If short-term use, see “pain medication” and “anti-anxiety” in DNF section.)
FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times · FAA date 30 September 2026
DO NOT FLY (DNF) MEDICATIONS
The following medications have aeromedically concerning safety profiles. All medications listed below may cause sedation or drowsiness, impairing cognitive function and seriously degrading pilot performance.
ANTI-ANXIETY
Including but not limited to:
alprazolam (Xanax)
lorazepam (Ativan)
temazepam (Restoril)
triazolam (Halcion)
Sources and dates: Other anti-anxiety medicationsTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.